Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer

NCT00214123 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT00214123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2004
Completion date
December 31, 2012
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer